Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2015 1
2016 1
2017 2
2018 1
2020 1
2021 5
2022 4
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C; Parkinson's Progression Markers Initiative. Siderowf A, et al. Among authors: lafontant de. Lancet Neurol. 2023 May;22(5):407-417. doi: 10.1016/S1474-4422(23)00109-6. Lancet Neurol. 2023. PMID: 37059509 Free PMC article.
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
Russo MJ, Orru CD, Concha-Marambio L, Giaisi S, Groveman BR, Farris CM, Holguin B, Hughson AG, LaFontant DE, Caspell-Garcia C, Coffey CS, Mollon J, Hutten SJ, Merchant K, Heym RG, Soto C, Caughey B, Kang UJ. Russo MJ, et al. Among authors: lafontant de. Acta Neuropathol Commun. 2021 Nov 6;9(1):179. doi: 10.1186/s40478-021-01282-8. Acta Neuropathol Commun. 2021. PMID: 34742348 Free PMC article.
LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates.
Chahine LM, Lafontant DE, Ho Choi S, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-Latapi P, Avants B, Coffey C, Jennings D, Tolosa E, Siderowf A, Marek K, Simuni T. Chahine LM, et al. Among authors: lafontant de. medRxiv [Preprint]. 2024 Jul 22:2024.07.22.24310806. doi: 10.1101/2024.07.22.24310806. medRxiv. 2024. PMID: 39108519 Free PMC article. Preprint.
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.
Markmann JF, Rickels MR, Eggerman TL, Bridges ND, Lafontant DE, Qidwai J, Foster E, Clarke WR, Kamoun M, Alejandro R, Bellin MD, Chaloner K, Czarniecki CW, Goldstein JS, Hering BJ, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Naji A, Oberholzer J, Posselt AM, Ricordi C, Senior PA, Shapiro AMJ, Stock PG, Turgeon NA. Markmann JF, et al. Among authors: lafontant de. Am J Transplant. 2021 Apr;21(4):1477-1492. doi: 10.1111/ajt.16174. Epub 2020 Aug 9. Am J Transplant. 2021. PMID: 32627352 Free PMC article. Clinical Trial.
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.
Picillo M, LaFontant DE, Bressman S, Caspell-Garcia C, Coffey C, Cho HR, Burghardt EL, Dahodwala N, Saunders-Pullman R, Tanner CM, Amara AW; Parkinson’s Progression Markers Initiative. Picillo M, et al. Among authors: lafontant de. J Parkinsons Dis. 2022;12(1):421-436. doi: 10.3233/JPD-212892. J Parkinsons Dis. 2022. PMID: 34744052 Free PMC article.
The Fibromyalgia Transcutaneous Electrical Nerve Stimulation in Physical Therapy Study Protocol: A Multisite Embedded Pragmatic Trial.
Post AA, Dailey DL, Bayman EO, Chimenti RL, Costigan M, Franck C, Huff T, Johnson E, Koepp M, Lafontant DE, McCabe ME, Neill-Hudson T, Vance CGT, Van Gorp B, Zimmerman BM, Ecklund D, Crofford LJ, Sluka KA. Post AA, et al. Among authors: lafontant de. Phys Ther. 2022 Nov 6;102(11):pzac116. doi: 10.1093/ptj/pzac116. Phys Ther. 2022. PMID: 36036838 Free PMC article.
Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
Russo MJ, Orru CD, Concha-Marambio L, Giaisi S, Groveman BR, Farris CM, Holguin B, Hughson AG, LaFontant DE, Caspell-Garcia C, Cofey CS, Mollon J, Hutten SJ, Merchant K, Heym RG, Soto C, Caughey B, Kang UJ. Russo MJ, et al. Among authors: lafontant de. Acta Neuropathol Commun. 2021 Nov 26;9(1):190. doi: 10.1186/s40478-021-01292-6. Acta Neuropathol Commun. 2021. PMID: 34836545 Free PMC article. No abstract available.
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease.
Gonzalez-Latapi P, Gochanour C, Cho H, Ho Choi S, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek K, Simuni T. Gonzalez-Latapi P, et al. Among authors: lafontant de. medRxiv [Preprint]. 2024 Oct 10:2024.10.09.24315191. doi: 10.1101/2024.10.09.24315191. medRxiv. 2024. PMID: 39417131 Free PMC article. Preprint.
Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease.
Espay AJ, Lafontant DE, Poston KL, Caspell-Garcia C, Marsili L, Cho HR, McDaniel C, Kim N, Coffey CS, Mahajan A, Ezzat K, Sturchio A; Parkinson's Progression Markers Initiative. Espay AJ, et al. Among authors: lafontant de. Parkinsonism Relat Disord. 2021 Nov;92:15-21. doi: 10.1016/j.parkreldis.2021.10.010. Epub 2021 Oct 13. Parkinsonism Relat Disord. 2021. PMID: 34656902
19 results